High-Density Surface Electromyography Assessment of Pelvic Floor Dysfunction in Women with Interstitial Cystitis/Bladder Pain Syndrome

No AccessJournal of UrologyAdult Urology1 Dec 2020High-Density Surface Electromyography Assessment of Pelvic Floor Dysfunction in Women with Interstitial Cystitis/Bladder Pain SyndromeThis article is commented on by the following:Editorial Comment Nicholas Dias, Chuan Zhang, Theresa Spitznagle, H. Henry Lai, and Yingchun Zhang Nicholas DiasNicholas Dias University of Houston, Department of Biomedical Engineering, Houston, Texas More articles by this author , Chuan ZhangChuan Zhang University of Houston, Department of Biomedical Engineering, Houston, Texas More articles by this author , Theresa SpitznagleTheresa Spitznagle Department of Physical Therapy, Washington University School of Medicine, St. Louis, Missouri More articles by this author , H. Henry LaiH. Henry Lai Departments of Surgery (Urology) and Anesthesiology, Washington University School of Medicine, St. Louis, Missouri More articles by this author , and Yingchun ZhangYingchun Zhang *Correspondence: Department of Biomedical Engineering, University of Houston, 4849 Calhoun Rd., Rm 373, Houston, Texas 77004 telephone: 713-743-6127; E-mail Address: [email protected] University of Houston, Department of Biomedical Engineering, Houston, Texas More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001237AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Up to 85% of women with interstitial cystitis/bladder pain syndrome have pelvic floor dysfunction and hypertonicity. Current evaluation methodologies lack objective measures of pelvic floor muscle activity. We examined the ability of using intravaginal high-density surface electromyography to quantitatively, objectively and noninvasively map pelvic floor muscle activity and innervation zone locations in patients with interstitial cystitis/bladder pain syndrome. Materials and Methods: Fifteen women with interstitial cystitis/bladder pain syndrome and 15 controls underwent 2 sessions of digital pelvic examinations and high-density surface electromyography assessments. The root mean squared amplitude of high-density surface electromyography was first calculated, and the resting root mean squared ratio was then calculated by normalizing the resting electromyography root mean squared to the peak electromyography amplitude reached during maximum voluntary contraction. Innervation zone distributions were obtained from decomposed high-density surface electromyography signals. The correlation between the root mean squared ratio and interstitial cystitis/bladder pain syndrome symptom scores and pelvic floor muscle alignment were investigated in patients with interstitial cystitis/bladder pain syndrome and healthy controls. Results: Women with interstitial cystitis/bladder pain syndrome demonstrated significantly increased resting root mean squared ratios compared to controls (0.155±0.048 vs 0.099±0.041, p=0.0019). Significant correlations were found between resting root mean squared ratio and patient reported pain (rs=0.523, p=0.003), interstitial cystitis symptom (rs=0.521, p=0.003) and problem indices (rs=0.60, p <0.001). In addition, women with interstitial cystitis/bladder pain syndrome were more likely to have shortened pelvic floor muscles (80%, 12 vs 13.3%, 2, p <0.01). Women with shortened pelvic floor muscles demonstrated significantly higher resting root mean squared ratio compared to those with normal pelvic floor muscle length (0.155±0.046 vs 0.107±0.040, p=0.0058). Conclusions: Intravaginal high-density surface electromyography offers an objective and quantitative strategy to noninvasively assess pelvic floor muscle dysfunction in women with interstitial cystitis/bladder pain syndrome. Abundant spatiotemporal muscle activity information captured by high-density surface electromyography allows for mapping innervation zone distributions for major pelvic floor muscles. References 1. : Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 2007; 70: 16. Google Scholar 2. : Pathophysiology of pelvic floor hypertonic disorders. Obstet Gynecol Clin 2009; 36: 699. Google Scholar 3. : Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin 2009; 36: 707. Google Scholar 4. : An update on botulinum toxin A injections of trigger points for myofascial pain. Curr Pain Headache Rep 2014; 18: 386. Google Scholar 5. : Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn 2008; 27: 306. Google Scholar 6. : Sacral neuromodulation as a treatment for chronic pelvic pain. J Urol 2011; 186: 387. Link, Google Scholar 7. : Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol 2012; 187: 2113. Link, Google Scholar 8. : Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Eur J Pain 2007; 11: 519. Google Scholar 9. : Diagnostic testing in fecal incontinence. Curr Gastroenterol Rep 2003; 5: 406. Google Scholar 10. : Functional mapping of the pelvic floor and sphincter muscles from high-density surface EMG recordings. Int Urogynecol J 2016; 27: 1689. Google Scholar 11. : Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 2015; 193: 1545. Link, Google Scholar 12. : The assessment of levator muscle strength: a validation of three ultrasound techniques. Int Urogynecol J 2002; 13: 156. Google Scholar 13. : Recognizing and treating pelvic pain and pelvic floor dysfunction. Phys Med Rehabil Clin N Am 2007; 18: 477. Google Scholar 14. : Development of a standardized, reproducible screening examination for assessment of pelvic floor myofascial pain. Am J Obstet Gynecol 2019; 220: 255.e1. Google Scholar 15. : Myofascial pelvic pain. Obstet Gynecol Clin 2014; 41: 409. Google Scholar 16. : SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods 2020; 17: 261. Google Scholar 17. : Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynecol 2005; 26: 107. Google Scholar 18. : Understanding multisymptom presentations in chronic pelvic pain: the inter-relationships between the viscera and myofascial pelvic floor dysfunction. Curr Pain Headache Rep 2011; 15: 343. Google Scholar 19. : Active and passive components of pelvic floor muscle tone in women with provoked vestibulodynia: a perspective based on a review of the literature. J Sex Med 2015; 12: 2178. Google Scholar 20. : Pelvic floor muscle dysfunctions are prevalent in female chronic pelvic pain: a cross-sectional population-based study. Eur J Pain 2014; 18: 1259. Google Scholar 21. : Surface electromyography diagnostics in women with partial vaginismus with or without vulvar vestibulitis and in asymptomatic women. J Psychosom Obstet Gynecol 2004; 25: 281. Google Scholar 22. : State of the art review: intravaginal probes for recording electromyography from the pelvic floor muscles. Neurourol Urodyn 2015; 34: 104. Google Scholar 23. : MRI suggests increased tonicity of the levator ani in women with interstitial cystitis/bladder pain syndrome. Int Urogynecol J 2016; 27: 77. Google Scholar 24. : A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000; 85: 101. Google Scholar 25. : Botulinum toxin A injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study. Female Pelvic Med Reconstr Surg 2015; 21: 277. Google Scholar 26. : Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain. Female Pelvic Med Reconstr Surg 2013; 19: 288. Google Scholar 27. : Botulinum toxin has an increased effect when targeted toward the muscle's endplate zone: a high-density surface EMG guided study. Clin Neurophysiol 2011; 122: 1611. Google Scholar 28. : An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J 2017; 28: 191. Google Scholar 29. : Are there trigger points in the spastic muscles? Electromyographical evidence of dry needling effects on spastic finger flexors in chronic stroke. Front Neurol 2020; 11: 78. Google Scholar 30. : Myofascial trigger points and innervation zone locations in upper trapezius muscles. BMC Musculoskelet Disord 2013; 14: 179. Google Scholar No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article. © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologySep 24, 2020, 12:00:00 AMEditorial Comment Volume 204Issue 6December 2020Page: 1275-1283Supplementary Materials Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.Keywordsmuscle hypertoniapelvic floorinterstitialelectromyographycystitismyofascial pain syndromesMetricsAuthor Information Nicholas Dias University of Houston, Department of Biomedical Engineering, Houston, Texas More articles by this author Chuan Zhang University of Houston, Department of Biomedical Engineering, Houston, Texas More articles by this author Theresa Spitznagle Department of Physical Therapy, Washington University School of Medicine, St. Louis, Missouri More articles by this author H. Henry Lai Departments of Surgery (Urology) and Anesthesiology, Washington University School of Medicine, St. Louis, Missouri More articles by this author Yingchun Zhang University of Houston, Department of Biomedical Engineering, Houston, Texas *Correspondence: Department of Biomedical Engineering, University of Houston, 4849 Calhoun Rd., Rm 373, Houston, Texas 77004 telephone: 713-743-6127; E-mail Address: [email protected] More articles by this author Expand All No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article. Advertisement Loading ...